Birsfelden, Switzerland

Peter Weber

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Drug'on Pharma Switzerland Ag. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Weber. Retrieved from https://idiyas.com/inventor/peter-weber-66qj1vsv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Peter Weber: Innovator in Pharmaceutical Chemistry

Introduction

Peter Weber is a notable inventor based in Birsfelden, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of specialized compounds. His work is characterized by a focus on innovative processes that enhance the efficacy of pharmaceutical products.

Latest Patents

Peter Weber holds a patent for a process for preparing salicyloyl-L-carnitine hydrochloride. This invention relates to a method for synthesizing 3-(2-hydroxybenzoyloxy)-4-(trimethylammonio)butyrobetaine hydrochloride, which involves reacting 3-hydroxy-4-(trimethylammonio)butyrobetaine or a salt thereof with a 2-alkoxybenzoyl chloride. The process is designed to produce compounds that are beneficial in various pharmaceutical applications.

Career Highlights

Peter Weber is currently associated with Drug'on Pharma Switzerland AG, where he continues to innovate in the pharmaceutical sector. His expertise in chemical processes has positioned him as a valuable asset to the company, contributing to its research and development efforts.

Collaborations

Peter collaborates with Thomas Meul, working together to advance their research initiatives and develop new pharmaceutical solutions.

Conclusion

Peter Weber's contributions to pharmaceutical chemistry through his innovative patent and collaboration with industry professionals highlight his role as a key inventor in the field. His work continues to influence the development of effective pharmaceutical compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…